secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001564590-22-037674
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ra Medical Systems reports Q3 2022 loss, no revenue; merger with Catheter Precision progressing
--------------------------------------------------------------------------------

- Q3 2022 revenue $0; loss from continuing ops $4.8M ($4.36/share) vs $7.4M loss in Q3 2021.
- Adjusted EBITDA negative $4.1M, improved from negative $6.9M in Q3 2021.
- Cash and equivalents $13.7M at Sept 30; raised ~$4.9M after quarter via ATM.
- Proposed reverse merger with Catheter Precision on track for late 2022/early 2023; Catheter stakeholders to own ~80%.
- Effected 1-for-50 reverse stock split on Oct 3 to maintain NYSE American listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000156459022037674/0001564590-22-037674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000156459022037674/rmed-8k_20221114.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-037674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer